January 6, 2025 11:58 AM EST
China
Manufacturing

WuXi Bi­o­log­ics to sell Irish vac­cine site to Mer­ck for $500M

Anna Brown

News Reporter

WuXi Bi­o­log­ics’ sub­sidiary WuXi Vac­cines is di­vest­ing a man­u­fac­tur­ing fa­cil­i­ty in Dun­dalk, Ire­land, to Mer­ck for $500 mil­lion, rough­ly a week af­ter WuXi AppTec al­so …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Vir’s ear­ly T cell en­gager da­ta of­fer first look at can­cer piv­ot, stock jumps

Up­dat­ed: Gala­pa­gos to split in­to two com­pa­nies, slash head­count as it eyes turn­around

ARCH, F-Prime and Mubadala pump $200M in­to for­mer De­nali pro­grams

Every FDA drug ap­proval from 2024: Few­er nods, but long-await­ed treat­ments cross the fin­ish line

Sana’s stock soars on new cell ther­a­py da­ta; UniQure’s $75M of­fer­ing

Maze files for first biotech IPO of 2025, fol­low­ing $115M fund­ing boost

A service from the Financial Times